TODAY’S TRADEMARK – KEFLEX

Cefalexin is an antibiotic that was developed in 1967. It was first marketed in 1969 and 1970 under the names Keflex and Ceporex, among others. Cephalexin Anhydrous is the anhydrous form of cephalexin, a semisynthetic first-generation cephalosporin with antibacterial activity. Cephalexin binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. The medication, Keflex, is used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. Common side effects of over dose include stomach upset and diarrhea.  

The trademark of this company was registered in USPTO bearing registration number 0881598 on December 2, 1969.